BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8509840)

  • 21. Engineered single chain antibody fragments for radioimmunotherapy.
    Huhalov A; Chester KA
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):279-88. PubMed ID: 15640791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-guided radiation therapy of cancer.
    Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
    Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies in the diagnosis and treatment of the colorectal cancer.
    Dziki A
    Acta Chir Iugosl; 1998; 45(2 Suppl):35-6. PubMed ID: 10951784
    [No Abstract]   [Full Text] [Related]  

  • 24. 4th Conference on Radioimmunodetection and Radioimmunotherapy of Cancer. Proceedings. Princeton, New Jersey, September 17-19, 1992.
    Cancer; 1994 Feb; 73(3 Suppl):757-1125. PubMed ID: 7905782
    [No Abstract]   [Full Text] [Related]  

  • 25. 5th conference on radioimmunodetection and radioimmunotherapy of cancer. October 6-8, 1994, Princeton, New Jersey. Program and abstracts.
    J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):142-72. PubMed ID: 7804529
    [No Abstract]   [Full Text] [Related]  

  • 26. Proceedings of the Sixth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer. Princeton, New Jersey, October 10-12, 1996.
    Cancer; 1997 Dec; 80(12 Suppl):2343-753. PubMed ID: 9406680
    [No Abstract]   [Full Text] [Related]  

  • 27. Preparation of a trivalent antigen-binding construct using polyoxime chemistry: improved biodistribution and potential for therapeutic application.
    Werlen RC; Lankinen M; Offord RE; Schubiger PA; Smith A; Rose K
    Cancer Res; 1996 Feb; 56(4):809-15. PubMed ID: 8631018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of methods for red marrow dosimetry based on patients undergoing radioimmunotherapy.
    Hindorf C; Lindén O; Tennvall J; Wingårdh K; Strand SE
    Acta Oncol; 2005; 44(6):579-88. PubMed ID: 16165917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A forum for IRIST.
    Van De Wiele C; Signore A
    Q J Nucl Med Mol Imaging; 2005 Dec; 49(4):299-300. PubMed ID: 16407811
    [No Abstract]   [Full Text] [Related]  

  • 30. Final results of a phase I radioimmunotherapy trial using (186)Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma.
    Postema EJ; Raemaekers JM; Oyen WJ; Boerman OC; Mandigers CM; Goldenberg DM; van Dongen GA; Corstens FH
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3995S-4002S. PubMed ID: 14506199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.
    Kraeber-Bodéré F; Faivre-Chauvet A; Ferrer L; Vuillez JP; Brard PY; Rousseau C; Resche I; Devillers A; Laffont S; Bardiès M; Chang K; Sharkey RM; Goldenberg DM; Chatal JF; Barbet J
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3973S-81S. PubMed ID: 14506196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Of mice and men..
    Perkins AC
    Eur J Nucl Med; 1992; 19(6):385-6. PubMed ID: 1618228
    [No Abstract]   [Full Text] [Related]  

  • 33. 13th Meeting of the International Research Group on Immunoscintigraphy and Immunotherapy (IRIST). 7-8 May 1999, Göttingen, Germany.
    Behr TM; Boerman OC
    Eur J Nucl Med; 1999 Aug; 26(8):950-2. PubMed ID: 10515718
    [No Abstract]   [Full Text] [Related]  

  • 34. Accelerated Blood Clearance of Antibodies by Nanosized Click Antidotes.
    Smith WJ; Wang G; Gaikwad H; Vu VP; Groman E; Bourne DWA; Simberg D
    ACS Nano; 2018 Dec; 12(12):12523-12532. PubMed ID: 30516974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoadsorption: an enhancement strategy for radioimmunotherapy.
    DeNardo GL; Maddock SW; Sgouros G; Scheibe PO; DeNardo SJ
    J Nucl Med; 1993 Jun; 34(6):1020-7. PubMed ID: 8509840
    [No Abstract]   [Full Text] [Related]  

  • 36. Quality control of radiolabeled monoclonal antibodies.
    Khazaeli MB
    Cancer Biother Radiopharm; 2000 Dec; 15(6):529-30. PubMed ID: 11190485
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetically engineered immunoconjugates: a dosimetric dilemma?
    Perkins AC
    Nucl Med Commun; 1993 Dec; 14(12):1047-9. PubMed ID: 8295759
    [No Abstract]   [Full Text] [Related]  

  • 38. A model for others: a strategy for improving diagnosis and therapy of human malignancies using monoclonal antibodies targeting TAG-72 oncofetal antigen.
    Larson SM
    Cancer Invest; 1993; 11(2):235-8. PubMed ID: 8462025
    [No Abstract]   [Full Text] [Related]  

  • 39. [Monoclonal antibodies. An approach to diagnosis and treatment of micrometastases].
    Bier H
    HNO; 1994 May; 42(5):255-6. PubMed ID: 8050912
    [No Abstract]   [Full Text] [Related]  

  • 40. Principles of radioimmunotherapy for hematologists and oncologists.
    Press OW; Rasey J
    Semin Oncol; 2000 Dec; 27(6 Suppl 12):62-73. PubMed ID: 11226002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.